Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;106(1):58-63.
doi: 10.1002/cyto.b.22142. Epub 2023 Sep 13.

Whole blood no-lyse no-wash micromethod for the quantitative measurement of monocyte HLA-DR

Affiliations
Free article

Whole blood no-lyse no-wash micromethod for the quantitative measurement of monocyte HLA-DR

Jordi Miatello et al. Cytometry B Clin Cytom. 2024 Jan.
Free article

Abstract

Background: Monocyte (m)HLA-DR expression appears to be a potent marker of immunosuppression in critically ill patients. The persistence of low mHLA-DR expression is associated with an increased risk of nosocomial infections and mortality. To adapt this measurement to pediatric requirements and provide extensive 24/7 access, we have developed a whole blood no-lyse no-wash micromethod (MM) and compared it with the standardized method (SM).

Methods: mHLA-DR was quantified by flow cytometry using Quantibrite™ Anti-HLA-DR PE/Monocyte PerCP-Cy™5.5 with either the SM performed in a diagnostic hematology laboratory using manufacturer protocol, or a whole blood no-lyse no-wash MM using an Attune flow cytometer located in the pediatric ICU. Median fluorescence intensity was measured in both techniques and converted to antibodies per cell (AB/C) calibrated with BD Quantibrite™ PE beads. Blood and Quantibrite™ reagent volume used with the MM was reduced by 5-fold compared to SM. In addition to Quantibrite™ Anti-Human HLA-DR PE/Monocyte PerCP-Cy™5.5, MM required anti-CD45 and anti-CD19 labeling.

Results: We determined the expression of mHLA-DR in 34 patients, 20 adults, and 14 children admitted to ICU. Correlation between MM and SM was excellent (Pearson's correlation: y = 0.8192x + 678.7, r = 0.9270, p < 0.0001). The estimated bias was 2467 ± 1.96 × 3307 AB/C; CI 95% [-4016; +8949].

Conclusions: The no-lyse no-wash whole blood microvolume method for measuring mHLA-DR expression allows for simplified sample preparation without compromising accuracy of the data. This method may simplify immune monitoring of critically ill patient by the deployment of a point of care method.

Keywords: HLA-DR; flow cytometry; immunosuppression; monocytes; sepsis.

PubMed Disclaimer

References

REFERENCES

    1. Bland, J. M., & Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet, 1, 307-310.
    1. Conway Morris, A., Datta, D., Shankar-Hari, M., Stephen, J., Weir, C. J., Rennie, J., Antonelli, J., Bateman, A., Warner, N., Judge, K., Keenan, J., Wang, A., Burpee, T., Brown, K. A., Lewis, S. M., Mare, T., Roy, A. I., Hulme, G., Dimmick, I., … Walsh, T. S. (2018). Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study. Intensive Care Medicine, 44, 627-635.
    1. de Roquetaillade, C., Dupuis, C., Faivre, V., Lukaszewicz, A. C., Brumpt, C., & Payen, D. (2022). Monitoring of circulating monocyte HLA-DR expression in a large cohort of intensive care patients: Relation with secondary infections. Annals of Intensive Care, 12, 39.
    1. Demaret, J., Walencik, A., Jacob, M.-C., Timsit, J.-F., Venet, F., Lepape, A., & Monneret, G. (2013). Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytometry, 84B, 59-62.
    1. Döcke, W.-D., Höflich, C., Davis, K. A., Röttgers, K., Meisel, C., Kiefer, P., Weber, S. U., Hedwig-Geissing, M., Kreuzfelder, E., Tschentscher, P., Nebe, T., Engel, A., Monneret, G., Spittler, A., Schmolke, K., Reinke, P., Volk, H.-D., & Kunz, D. (2005). Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: A multicenter standardized study. Clinical Chemistry, 51, 2341-2347.

LinkOut - more resources